to its Board of Directors. Dr. Hughes brings extensive experience from his leadership roles at major biopharmaceutical companies, including Vertex Pharmaceuticals and Novartis. Monte Rosa's CEO ...
Vertex Pharmaceuticals (VRTX ... From 2012 (when our Director of Research Sheraz Mian assumed responsibility for the portfolio) through November, 2024, the Zacks Top 10 Stocks gained +2,112.6 ...
Analyst Evan Seigerman of BMO Capital maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), retaining the price target of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback